EFFICACY OF PANAVIR® AND ACYCLOVIR IN THE COMPLEX THERAPY OF HERPETIC INFECTION-COMPLICATED RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1996-7012-2009-539
Abstract
Objective: to evaluate the efficiency of antiviral therapy in patients with herpetic infection-complicated rheumatoid arthritis (RA) who receive the basic therapy.
Subjects and methods. One hundred and thirty patients with recurrent herpesvirus infection were enrolled in the prospective comparative study. The patients were divided into 3 groups: 1) in addition to the basic therapy, the patients received Panavir®; 2) those who took Acyclovir; and 3) those who had the basic therapy alone. In 90 of the 130 examinees, high titers of antiviral IgG antibodies to cytomegalovirus and Epstein-Barr virus were found in 60 and 48,8%, respectively. The interferon-deficiency syndrome was diagnosed in 72 (80,0%) patients. Results. Virostatic therapy may be recommended for patients with RA concurrent with recurrent herpesvirus infection.
Subjects and methods. One hundred and thirty patients with recurrent herpesvirus infection were enrolled in the prospective comparative study. The patients were divided into 3 groups: 1) in addition to the basic therapy, the patients received Panavir®; 2) those who took Acyclovir; and 3) those who had the basic therapy alone. In 90 of the 130 examinees, high titers of antiviral IgG antibodies to cytomegalovirus and Epstein-Barr virus were found in 60 and 48,8%, respectively. The interferon-deficiency syndrome was diagnosed in 72 (80,0%) patients. Results. Virostatic therapy may be recommended for patients with RA concurrent with recurrent herpesvirus infection.
About the Authors
O N EgorovaR M Balabanova
N E Lopatina
A K Kaptayeva
T P Fedina
E G Sazhina
E L Nasonov
G N Chuvirov
References
1. <div><p>Kelaidi C., Tulliez M., Lecoq-Lafon C. et al. Long-term remission of an EBV-positive B cell lymphoproliferative disorder associated with rheumatoid arthritis under methotrexate with anti-CD20 monoclonal antibody (Rituximab) monotherapy. Leukemia 2002;16(10):2173-4.</p><p>Torre-Cisneros J., Del Castillo M., Castцn J.J. et al. Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis. Rheumatology 2005;44(9):1132-5.</p><p>Curtis J.R., Patkar N., Xie A. et al. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists. Arthritis Rheum 2007;56(4):1125-33.</p><p>Balandraud N., Guis S., Meynard J.B. et al. Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis. Arthritis Rheum 2007;57(5):762-7.</p><p>Belin V., Tebib J., Vignon E. Cytomegalovirus infection in a patient with rheumatoid arthritis. Joint Bone Spine 2003;70(4):303-6.</p><p>Kojima M., Motoori N., Itoh H. et al. Disnribution of Epstein-Barr virus in systemic rheumatic disease ( rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: a study of 49 cases. Int J Surg Pathol 2005;13(3):273-8.</p><p>Chim C.S., Pang Y.Y., Ooi G.C. et al. EBV-associated synovial lymphoma in a chronically inflamed joint in rheumatoid arthritis receiving prolonged methotrexate treatment. Haematologica 2006;91 (8 Suppl):ECR31.</p><p>Balandraud N., Roudier J., Roudier C. What are the links between Epstein-Barr virus, lymphoma and tumor necrosis factor antagonism in rheumatoid arthritis? Semin Arthritis Rheum 2005;34(5 Suppl 1):31-3.</p><p>Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека. СПб., 2006; с. 12-150.</p><p>Alvarez-Lafuente R., Fernandez-Gutierrez B., de Miguel S. et al. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis 2005;64(9):1357-9.</p><p>Zaher S.S., Sandinha T., Roberts F. et al. Herpes simplex keratitis misdiagnosed as rheumatoid arthritis-related peripheral ulcerative keratitis. Cornea 2005;24(8):1015-7.</p><p>Баринский И.Ф., Бикбулатова Р.М. Герпесвирусные инфекции (диагностика и лечение). М., 1990; с. 77-81.</p><p>Сомов Е.Е. Герпетические и эпидемические вирусные кератоконъюнктивиты. СПб., 1996.</p><p>Шабалин А.Р., Конопля Е.А., Конопля А.И. Влияние комплексной терапии на показатели иммунного статуса и клинику урогенитального герпеса. Вестн дерматол венерол 2004;2:48-50.</p><p>Posnett D.N., Yarilin D. Amplification of autoimmune disease by infection. Art Res Ther 2005;7:74-84.</p><p>Чувиров Г.Н., Маркова Т.П. Актуальные вопросы противовирусной терапии. РМЖ 2002;10(3):115-8.</p><p>Сергиенко В.И. Противовирусные свойства препарата «Панавир». М., 2005;5-111.</p><p>Grootscholten C., Ligtenberg G., Hagen E.C. et al. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int 2006;70(4):732-42.</p><p>Wolfe F., Michaud K., Chakravarty E.F. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and noninflammatory musculoskeletal disorders. Rheumatology 2006;45(11):1370-5.</p><p>Beam T.R., Gilbert D.N., Kunin C.M. Европейское руководство по клинической оценке противоинфекционных лекарственных средств. М., 1996;119-26.</p><p>Fujinami R.S., von Herrath M.G., Christen U. et al. Molecular mimicry, bystanderactivation, or viral persistence: infections and autoimmune disease. Clin Microb Rev 2006;19(1):80-94.</p><p>Dworkin R.H., Johnson R.W., Breuer J. et al. Management of Herpes Zoster. Clinical Ifect Dis 2007:44:1-26.</p><p>Mancuso R., Delbue S., Borghi E. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol 2007;79(2):192-9.</p><p>Егорова О.Н., Балабанова Р.М. Противовирусная терапия при ревматических заболеваниях. Фарматека 2007;6:90-4.</p><p>Петров А.В., Дударь Л.В., Малый К.Д. Персистенция различных инфекционных агентов в мононуклеарных лейкоцитах крови в дебюте ревматоидного артрита. Тер арх 2004;5:78-81.</p><p>Agarwal V., Singh R., Chauhan S. Remission of rheumatoid arthritis after acute disseminated varicella-zoster infection. Clin Rheumatol 2006;21:1-2.</p><p>Izumikawa K., Morinaga Y., Kondo A. et al. Adult Still's disease associated with cytomegalovirus infection. J Infect Chemother 2007;13(2):114-7.</p><p>Балабанова Р.М., Сальникова Т.С., Сороцкая В.Н. Первый опыт применения противовирусного препарата цимевена в комплексной терапии ревматоидного артрита. Ревматология 2001;5:87-91.</p></div><br />
Review
For citations:
Egorova ON, Balabanova RM, Lopatina NE, Kaptayeva AK, Fedina TP, Sazhina EG, Nasonov EL, Chuvirov GN. EFFICACY OF PANAVIR® AND ACYCLOVIR IN THE COMPLEX THERAPY OF HERPETIC INFECTION-COMPLICATED RHEUMATOID ARTHRITIS. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2009;3(2):42-47. (In Russ.) https://doi.org/10.14412/1996-7012-2009-539
Views:
8289
Email this article 